104 related articles for article (PubMed ID: 7753712)
1. Inhibition of prostate cancer growth by vinblastine and tamoxifen.
Pienta KJ; Replogle T; Lehr JE
Prostate; 1995 May; 26(5):270-4. PubMed ID: 7753712
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of prostate cancer growth by estramustine and colchicine.
Fakih M; Yagoda A; Replogle T; Lehr JE; Pienta KJ
Prostate; 1995 Jun; 26(6):310-5. PubMed ID: 7784270
[TBL] [Abstract][Full Text] [Related]
3. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.
Naik HR; Lehr JE; Pienta KJ
Anticancer Res; 1994; 14(6B):2617-9. PubMed ID: 7872690
[TBL] [Abstract][Full Text] [Related]
4. Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats.
Naik H; Lehr J; Akhtar A; Pienta K
Anticancer Res; 1994; 14(6B):2681-4. PubMed ID: 7872701
[TBL] [Abstract][Full Text] [Related]
5. A phase II evaluation of oral tamoxifen and intermittent intravenous vinblastine in hormone-refractory adenocarcinoma of the prostate.
Pienta KJ; Redman BG; Esper PS; Flaherty LE
Am J Clin Oncol; 1996 Oct; 19(5):500-3. PubMed ID: 8823479
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
7. Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo.
Garde S; Sheth A; Porter AT; Pienta KJ
Prostate; 1993; 22(3):225-33. PubMed ID: 8488155
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of prostate cancer growth by 9-aminocamptothecin and estramustine.
Naik H; Lehr JE; Pienta KJ
Urology; 1996 Sep; 48(3):508-11. PubMed ID: 8804514
[TBL] [Abstract][Full Text] [Related]
9. Effects of microtubule inhibitors-taxol, vinblastine and estramustine on the growth and p53 gene expression in the hormone independent human prostatic JCA-1 cells.
Darby E; An S; Ng C; Hsieh TC; Mallouh C; Wu JM
Anticancer Res; 1996; 16(6B):3647-52. PubMed ID: 9042236
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of MAT LyLu: a Dunning rat prostate adenocarcinoma tumor subline.
Wenger AS; Mickey DD; Hall M; Silverman LM; Mickey GH; Fried FA
J Urol; 1984 Jun; 131(6):1232-6. PubMed ID: 6539387
[TBL] [Abstract][Full Text] [Related]
11. Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma.
Arah IN; Dixon SC; Horti J; Figg WD
Neoplasma; 1999; 46(2):117-23. PubMed ID: 10466436
[TBL] [Abstract][Full Text] [Related]
12. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen enhances the chemosensitivity of bladder carcinoma cells.
Pu YS; Hsieh TS; Tsai TC; Cheng AL; Hsieh CY; Su IJ; Lai MK
J Urol; 1995 Aug; 154(2 Pt 1):601-5. PubMed ID: 7609145
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of prostate cancer growth by estramustine and etoposide: evidence for interaction at the nuclear matrix.
Pienta KJ; Lehr JE
J Urol; 1993 Jun; 149(6):1622-5. PubMed ID: 8501820
[TBL] [Abstract][Full Text] [Related]
15. Potentiation by estramustine of the cytotoxic effect of vinblastine and doxorubicin in prostatic tumor cells.
Batra S; Karlsson R; Witt L
Int J Cancer; 1996 Nov; 68(5):644-9. PubMed ID: 8938148
[TBL] [Abstract][Full Text] [Related]
16. The effect of hydrazine sulfate on prostate cancer growth.
Kamradt JM; Pienta KJ
Oncol Rep; 1998; 5(4):919-21. PubMed ID: 9625846
[TBL] [Abstract][Full Text] [Related]
17. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
Ip MM; Milholland RJ; Rosen F
Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy increases the efficacy of docetaxel, vinblastine and tamoxifen in cancer cells.
Samadi N; Ghanbari P; Mohseni M; Tabasinezhad M; Sharifi S; Nazemieh H; Rashidi MR
J Cancer Res Ther; 2014; 10(3):715-21. PubMed ID: 25313766
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer.
Hamilton M; Dahut W; Brawley O; Davis P; Wells-Jones T; Kohler D; Duray P; Liewehr DJ; Lakhani N; Steinberg SM; Figg WD; Reed E
Acta Oncol; 2003; 42(3):195-201. PubMed ID: 12852695
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.
Pienta KJ; Naik H; Akhtar A; Yamazaki K; Replogle TS; Lehr J; Donat TL; Tait L; Hogan V; Raz A
J Natl Cancer Inst; 1995 Mar; 87(5):348-53. PubMed ID: 7853416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
